Concepts (156)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cell Cycle Proteins | 8 | 2015 | 384 | 1.160 |
Why?
|
| Nuclear Proteins | 9 | 2019 | 750 | 1.030 |
Why?
|
| F-Box Proteins | 4 | 2021 | 15 | 0.990 |
Why?
|
| DNA-Binding Proteins | 8 | 2015 | 1151 | 0.890 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2025 | 475 | 0.720 |
Why?
|
| Neoplasms | 3 | 2024 | 1240 | 0.620 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2018 | 194 | 0.590 |
Why?
|
| Tumor Suppressor Protein p53 | 3 | 2015 | 289 | 0.570 |
Why?
|
| Mutagens | 1 | 2015 | 20 | 0.490 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2015 | 32 | 0.490 |
Why?
|
| Interleukin-8 | 1 | 2014 | 86 | 0.460 |
Why?
|
| Cell Division | 1 | 2015 | 443 | 0.440 |
Why?
|
| Phagocytosis | 2 | 2024 | 249 | 0.410 |
Why?
|
| NF-kappa B | 1 | 2014 | 458 | 0.400 |
Why?
|
| Macrophages | 3 | 2024 | 1000 | 0.330 |
Why?
|
| Cell Line, Tumor | 8 | 2025 | 1368 | 0.330 |
Why?
|
| Proteolysis | 3 | 2021 | 136 | 0.320 |
Why?
|
| Apoptosis | 5 | 2024 | 1032 | 0.300 |
Why?
|
| Homeostasis | 1 | 2010 | 346 | 0.290 |
Why?
|
| bcl-2-Associated X Protein | 2 | 2021 | 42 | 0.270 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 2 | 2018 | 42 | 0.270 |
Why?
|
| Gene Expression Regulation | 2 | 2010 | 1547 | 0.270 |
Why?
|
| Apoptosis Regulatory Proteins | 2 | 2021 | 146 | 0.260 |
Why?
|
| Proto-Oncogene Protein c-fli-1 | 1 | 2025 | 5 | 0.240 |
Why?
|
| RNA-Binding Protein EWS | 1 | 2025 | 8 | 0.240 |
Why?
|
| Sarcoma, Ewing | 1 | 2025 | 11 | 0.240 |
Why?
|
| Galactosyltransferases | 1 | 2025 | 16 | 0.240 |
Why?
|
| Proto-Oncogene Proteins | 2 | 2021 | 318 | 0.240 |
Why?
|
| Image Cytometry | 1 | 2024 | 2 | 0.240 |
Why?
|
| WNK Lysine-Deficient Protein Kinase 1 | 1 | 2024 | 5 | 0.230 |
Why?
|
| CD24 Antigen | 1 | 2024 | 18 | 0.230 |
Why?
|
| Acyltransferases | 1 | 2024 | 31 | 0.220 |
Why?
|
| Bone Neoplasms | 1 | 2025 | 115 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2024 | 96 | 0.220 |
Why?
|
| Ovarian Neoplasms | 1 | 2024 | 130 | 0.210 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2023 | 86 | 0.200 |
Why?
|
| Tumor Microenvironment | 1 | 2023 | 140 | 0.200 |
Why?
|
| Transcription Factor RelA | 2 | 2014 | 50 | 0.190 |
Why?
|
| Mycobacterium tuberculosis | 3 | 2015 | 390 | 0.190 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2014 | 229 | 0.180 |
Why?
|
| Immunotherapy | 1 | 2023 | 230 | 0.180 |
Why?
|
| DNA Damage | 4 | 2018 | 279 | 0.180 |
Why?
|
| Promoter Regions, Genetic | 5 | 2017 | 650 | 0.170 |
Why?
|
| Breast Neoplasms | 2 | 2021 | 1118 | 0.160 |
Why?
|
| MCF-7 Cells | 2 | 2021 | 65 | 0.160 |
Why?
|
| fas Receptor | 2 | 2017 | 55 | 0.160 |
Why?
|
| Transcriptional Activation | 2 | 2011 | 188 | 0.160 |
Why?
|
| Humans | 17 | 2025 | 59282 | 0.160 |
Why?
|
| Acetylation | 3 | 2014 | 112 | 0.160 |
Why?
|
| Multiple Myeloma | 1 | 2024 | 325 | 0.160 |
Why?
|
| Histone Deacetylase 1 | 3 | 2014 | 18 | 0.160 |
Why?
|
| beta Catenin | 1 | 2019 | 86 | 0.150 |
Why?
|
| Phosphorylation | 3 | 2018 | 882 | 0.150 |
Why?
|
| Anaphase-Promoting Complex-Cyclosome | 1 | 2018 | 9 | 0.150 |
Why?
|
| Genes, Tumor Suppressor | 2 | 2019 | 70 | 0.150 |
Why?
|
| Amidohydrolases | 3 | 2024 | 35 | 0.140 |
Why?
|
| Mice | 10 | 2025 | 10251 | 0.140 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 55 | 0.140 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2018 | 188 | 0.130 |
Why?
|
| Pyrazinamide | 2 | 2006 | 7 | 0.130 |
Why?
|
| Antibodies | 1 | 2017 | 179 | 0.130 |
Why?
|
| Animals | 11 | 2025 | 19601 | 0.130 |
Why?
|
| Antitubercular Agents | 2 | 2006 | 76 | 0.120 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2017 | 147 | 0.120 |
Why?
|
| Cell Line | 3 | 2015 | 1968 | 0.120 |
Why?
|
| Protein Binding | 3 | 2014 | 1554 | 0.120 |
Why?
|
| Transcription, Genetic | 3 | 2014 | 844 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2015 | 63 | 0.120 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 1 | 2015 | 109 | 0.110 |
Why?
|
| Immunoblotting | 1 | 2014 | 187 | 0.110 |
Why?
|
| RNA Interference | 2 | 2014 | 590 | 0.110 |
Why?
|
| Xenograft Model Antitumor Assays | 2 | 2025 | 178 | 0.110 |
Why?
|
| Tuberculosis | 2 | 2015 | 270 | 0.110 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2015 | 256 | 0.110 |
Why?
|
| ras Proteins | 1 | 2013 | 77 | 0.110 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 527 | 0.110 |
Why?
|
| Signal Transduction | 4 | 2025 | 2888 | 0.100 |
Why?
|
| p300-CBP Transcription Factors | 1 | 2011 | 10 | 0.100 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 2046 | 0.090 |
Why?
|
| Cell Cycle | 2 | 2010 | 382 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2017 | 582 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2013 | 378 | 0.090 |
Why?
|
| Genes, bcl-1 | 1 | 2010 | 2 | 0.090 |
Why?
|
| Asthma | 1 | 2015 | 452 | 0.090 |
Why?
|
| Matrix Attachment Regions | 1 | 2010 | 4 | 0.090 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2009 | 583 | 0.080 |
Why?
|
| CD40 Antigens | 1 | 2009 | 61 | 0.080 |
Why?
|
| Neoplasm Invasiveness | 1 | 2010 | 250 | 0.080 |
Why?
|
| Transforming Growth Factor beta | 1 | 2010 | 167 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2015 | 1298 | 0.080 |
Why?
|
| I-kappa B Kinase | 1 | 2008 | 48 | 0.080 |
Why?
|
| HEK293 Cells | 2 | 2021 | 586 | 0.070 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2006 | 189 | 0.060 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2006 | 83 | 0.060 |
Why?
|
| Models, Biological | 3 | 2018 | 1140 | 0.060 |
Why?
|
| Ubiquitination | 2 | 2018 | 106 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2024 | 95 | 0.060 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2025 | 54 | 0.060 |
Why?
|
| Glycosylphosphatidylinositols | 1 | 2024 | 24 | 0.060 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 2024 | 42 | 0.060 |
Why?
|
| Hedgehog Proteins | 1 | 2025 | 109 | 0.060 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2024 | 238 | 0.050 |
Why?
|
| RNA, Small Interfering | 3 | 2018 | 855 | 0.050 |
Why?
|
| Epigenesis, Genetic | 2 | 2017 | 357 | 0.050 |
Why?
|
| CRISPR-Cas Systems | 1 | 2025 | 333 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2021 | 178 | 0.040 |
Why?
|
| Cell Proliferation | 1 | 2024 | 940 | 0.040 |
Why?
|
| Epithelial-Mesenchymal Transition | 1 | 2019 | 63 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 71 | 0.040 |
Why?
|
| Cdc20 Proteins | 1 | 2018 | 5 | 0.040 |
Why?
|
| Cell Cycle Checkpoints | 1 | 2018 | 46 | 0.040 |
Why?
|
| Cadherins | 1 | 2018 | 69 | 0.040 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2018 | 121 | 0.040 |
Why?
|
| Gene Knockdown Techniques | 1 | 2018 | 194 | 0.030 |
Why?
|
| Neoplasm Transplantation | 1 | 2017 | 161 | 0.030 |
Why?
|
| Gene Knockout Techniques | 1 | 2017 | 86 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2018 | 341 | 0.030 |
Why?
|
| Up-Regulation | 1 | 2017 | 365 | 0.030 |
Why?
|
| Cell Nucleus | 1 | 2019 | 606 | 0.030 |
Why?
|
| Cell Survival | 1 | 2017 | 559 | 0.030 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2015 | 64 | 0.030 |
Why?
|
| Th1 Cells | 1 | 2015 | 174 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2015 | 216 | 0.030 |
Why?
|
| DNA | 2 | 2010 | 806 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2015 | 191 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2015 | 144 | 0.030 |
Why?
|
| Blotting, Western | 1 | 2015 | 583 | 0.030 |
Why?
|
| Gene Expression Profiling | 1 | 2017 | 716 | 0.030 |
Why?
|
| Interferon-gamma | 1 | 2015 | 551 | 0.030 |
Why?
|
| NIH 3T3 Cells | 1 | 2013 | 95 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2015 | 639 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1204 | 0.020 |
Why?
|
| HCT116 Cells | 1 | 2011 | 48 | 0.020 |
Why?
|
| DNA Methylation | 1 | 2013 | 271 | 0.020 |
Why?
|
| Female | 2 | 2024 | 30695 | 0.020 |
Why?
|
| Promyelocytic Leukemia Protein | 1 | 2010 | 15 | 0.020 |
Why?
|
| Janus Kinases | 1 | 2009 | 17 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2015 | 1985 | 0.020 |
Why?
|
| STAT1 Transcription Factor | 1 | 2009 | 35 | 0.020 |
Why?
|
| Transfection | 1 | 2011 | 675 | 0.020 |
Why?
|
| Serine | 1 | 2009 | 83 | 0.020 |
Why?
|
| Mutation | 1 | 2017 | 2452 | 0.020 |
Why?
|
| Cytoplasm | 1 | 2009 | 270 | 0.020 |
Why?
|
| Histone Deacetylases | 1 | 2008 | 62 | 0.020 |
Why?
|
| Protein Transport | 1 | 2009 | 394 | 0.020 |
Why?
|
| Protein Multimerization | 1 | 2008 | 169 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2015 | 3220 | 0.020 |
Why?
|
| Down-Regulation | 1 | 2008 | 305 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 1300 | 0.020 |
Why?
|
| Culture Media | 1 | 2006 | 77 | 0.020 |
Why?
|
| Binding Sites | 1 | 2008 | 881 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 1949 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2006 | 1025 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 1093 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 1561 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2010 | 1470 | 0.010 |
Why?
|